InvestorsHub Logo
Followers 0
Posts 350
Boards Moderated 0
Alias Born 05/08/2015

Re: dranesthesia1 post# 24102

Thursday, 11/10/2016 5:16:40 PM

Thursday, November 10, 2016 5:16:40 PM

Post# of 73665
I know that i've been consistently criticized for not being overly positive here, but generally speaking, just about everything i've said hasn't been too far off. My issue with what is going on here is that the company is telling me that Redwood has nothing to do with this and I feel like they are just point blank lying, which throughout my life means I can't trust anything they say moving forward and that's ultimately what makes a public company promising or a failure. The fluff piece they put out yesterday worries me even more because two days ago they told me they haven't even received back information on their trial patches, so how are they going to market in "just a few weeks" with a product they haven't even received back market data on? You don't just enter a market and spend serious money without a plan on sales and how do you create a plan on sales if you dont have reviews on the product? They reference a 112B pain management market, but the bulk of that market is actual real pain killers, which I don't care how you want to spin it, they aren't competing in that market. By their claims, they are competing in the patch market, which is 1000th the size of what they are referencing, then eventually if they get into the pills, they will still only be competing in the more holistic side. I just feel they are being very misleading. Being misleading in OTC just leads to being more misleading.

Hopefully im wrong as hell.